ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03301636
Brief Title: A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma (NLG2107)

First Submitted : September 29, 2017
First Submitted that Met QC Criteria : September 29, 2017
First Posted : October 4, 2017

Last Update Submitted that Met QC Criteria : January 5, 2018
Last Update Posted : January 9, 2018